Thursday, June 4, 2026
HomeInvestingCompany News for May 13, 2026

Company News for May 13, 2026

  • Simon Property Group Inc.’s (SPG) shares gained 2.3% after reporting first-quarter 2026 adjusted FFO of $3.17 per share, beating the Zacks Consensus Estimate of $2.98 per share.
  • Shares of Hims & Hers Health Inc. (HIMS) plummeted 14.1% after posting first-quarter 2026 revenues of $608.10 million, missing the Zacks Consensus Estimate of $619.62 million.
  • Shares of Novanta Inc. (NOVT) jumped 13.7% after the company reported first-quarter 2026 adjusted earnings of $0.81 per share, surpassing the Zacks Consensus Estimate of $0.78 per share.
  • Halozyme Therapeutics Inc.’s (HALO) shares climbed 6.8% after the company posted first-quarter 2026 adjusted earnings of $1.60 per share, outpacing the Zacks Consensus Estimate of $1.54 per share. 

Zacks’ Research Chief Names “Stock Most Likely to Double”

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company’s customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Simon Property Group, Inc. (SPG) : Free Stock Analysis Report

Halozyme Therapeutics, Inc. (HALO) : Free Stock Analysis Report

Novanta Inc. (NOVT) : Free Stock Analysis Report

Hims & Hers Health, Inc. (HIMS) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

www.nasdaq.com

RELATED ARTICLES

Most Popular

Recent Comments